Samidorphan Completed Phase 2 Trials for Binge Eating Disorder (BED) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01098435ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder